Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkrw who wrote (2795)	5/17/1999 12:17:00 PM
From: sam	Read Replies (1) of 10280

Sepracor Inc. (SEPR) 77 7/8 -0 7/8: Lehman Brothers sees a buying opportunity on the weakness resulting from Johnson and Johnson's (JNJ 91 1/2 -1 3/8) decision not to exercise its option to co-promote norastemizole, Sepracore will post the clinical trial results of the non-sedating allergy drug on its website today, a move Lehman applauds..... So far, we have MSCO and LEH on the positive side. And MLCO on the negative.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next